STOCK TITAN

Barnes Group Inc. - B STOCK NEWS

Welcome to our dedicated news page for Barnes Group (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barnes Group.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Barnes Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Barnes Group's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
none
-
Rhea-AI Summary
BioArctic's partner Eisai announces positive results from Phase 3 Clarity AD study of lecanemab-irmb for Alzheimer's disease treatment. New data on subcutaneous formulation also promising.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
dividends
Rhea-AI Summary
Helzberg Diamonds has partnered with embedded insurance leader, Zillion, to offer customers one-click insurance coverage at the point of sale. By utilizing Zillion's platform, customers can receive an instant insurance quote and enjoy coverage while they decide. This frictionless experience aims to meet changing consumer expectations and accelerate Helzberg's digitally-centric strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
-
Rhea-AI Summary
BioArctic's partner Eisai will present the latest findings on lecanemab, an anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer's disease, at the Alzheimer's Association International Conference (AAIC). The conference will be held in Amsterdam, the Netherlands and virtually from July 16 to 20, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
Rhea-AI Summary
BioArctic's partner Eisai receives unanimous vote from FDA advisory committee on the clinical benefit of LEQEMBI for Alzheimer's disease. The PDUFA action date for traditional approval is set for July 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Barnes Group Inc.

NYSE:B

B Rankings

B Stock Data

1.72B
45.58M
9.12%
92.61%
2.06%
Aircraft Engine and Engine Parts Manufacturing
Manufacturing
Link
US
Bristol

About B

barnes group inc. is an international industrial and aerospace manufacturer and service provider, serving a wide range of end markets and customers. the highly engineered products, differentiated industrial technologies, and innovative solutions delivered by barnes group are used in far-reaching applications that provide transportation, manufacturing, healthcare products, and technology to the world. with approximately 4,700 dedicated employees, at more than 60 locations worldwide, on four continents across the globe, barnes group continues to build on our long-standing tradition of excellence in precision manufacturing and logistics solutions, while at the same time, investing in leading-edge technologies and applying our expertise in newer break-through markets. barnes group operates under two global business segments - industrial and aerospace. at barnes group, there are no limits to your career path - only opportunities for success! explore your future and career potential at